Decreased central histamine in the amygdaloid kindling rats

Brain Research

Volumn 802, Issue 1-2, 1998, Pages 241-246

  Toyota, Hiroshi ^a,b   Ito, Chihiro ^a   Ohsawa, Mariko ^a   Sakurai, Eiko ^a   Sato, Mitsumoto ^a   Watanabe, Takehiko ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Histamine; Histidine decarboxylase; Kindling; Seizure susceptibility

Indexed keywords

HISTAMINE; HISTIDINE DECARBOXYLASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DIENCEPHALON; DISEASE PREDISPOSITION; ELECTROSTIMULATION; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEIZURE; STATISTICAL ANALYSIS;

AMYGDALA; ANIMALS; BRAIN; DISEASE SUSCEPTIBILITY; HISTIDINE DECARBOXYLASE; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TISSUE DISTRIBUTION;

EID: 0344734177     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00637-4     Document Type: Article

References (38)

1. E. Bernstein, B.M. Diskant, Phenylpropanolamine: a potentially hazardous drug, Ann. Emerg. Med. 11 (1982) 311-315.
2. S. Bischoff, J. Korf, Different localization of histidine decarboxylase and histamine-N-methyl-transferase in the rat brain, Brain Res. 141 (1978) 375-379.
3. R. Cacabelos, Histaminergic regulation of the neuroendocrine system (NES), in: T. Watanabe, H. Wada (Eds.), Histaminergic Neurons: Morphology and Function, CRC Press, New York, 1991, pp. 241-270.
4. J.A. Churchill, G.D. Gamonn, The effect of antihistaminic drugs on convulsive seizures, J. Am. Med. Assoc. 141 (1949) 18-21.
5. 3H]DOPA in various regions of the brain, J. Neurochem. 13 (1966) 655-669.
6. G.V. Goddard, D.C. Mcintyre, C.K. Leech, A permanent change in brain function resulting from daily electrical stimulation, Exp. Neurol. 25 (1969) 295-330.
7. 1, receptors in complex partial seizure, Lancet 341 (1993) 238.
8. E.W. Kairiss, R.J. Racine, G.K. Smith, The development of interictal spike during kindling in the rat, Brain Res. 322 (1984) 101-110.
9. M.W. Kalichman, Neurochemical correlates of the kindling model of epilepsy, Neurosci. Behav. Rev. 6 (1982) 165-181.
10. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
11. J.O. Mcnamara, L.C. Rigsbee, L.S. Butler, C. Shin, Intravenous phenytoin is an effective anticonvulsant in the kindling model, Ann. Neurol. 26 (1989) 675-678.
12. M.S. Mueller, Phenylpropanolamine: a nonprescription drug with potentially fatal side effects, N. Engl. J. Med. 308 (1983) 653.
13. K. Onodera, L. Tuomisto, U. Tacke, M. Airaksinen, Strain differences in regional brain histamine levels between genetically epilepsy-prone and resistant rats, Methods Find. Exp. Clin. Pharmacol. 14 (1992) 13-16.
14. K. Onodera, A. Yamatodani, T. Watanabe, H. Wada, Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders, Prog. Neurobiol. 42 (1994) 685-702.
15. L.J. Pellegrino, A.J. Pellegrino, A.J. Cushman (Eds.), A Stereotaxic Atlas of the Rat Brain, Plenum, New York, 1979, pp. 1-122.
16. G.D. Prell, J.P. Green, Histamine as a neuroregulator, Annu. Rev. Neurosci. 9 (1986) 209-254.
17. R.J. Racine, Modification of seizure activity by electrical stimulation: II. Motor seizure, Electroenceph. Clin. Neurophysiol. 32 (1972) 281-294.
18. M. Sato, R.J. Racine, D.C. Mcintyre, Kindling: basic mechanisms and clinical validity, Electroencephalogr. Clin. Neurophysiol. 76 (1990) 459-472.
19. J.C. Schwartz, J.H. Patterson, Toxic encephalopathy related to antihistamine-barbiturate antiemetic medication, Am. J. Dis. Child. 132 (1978) 37-39.
20. J.C. Schwartz, J.M. Arrang, M. Garbarg, H. Pollard, M. Rust, Histaminergic transmission in the mammalian brain, Physiol. Rev. 71 (1991) 1-51.
21. P.A. Shore, A. Burkhalter, A.V.H. Cohn, A method for the fluorometric assay of histamine in tissues, J. Pharmacol. Exp. Ther. 127 (1959) 182-186.
22. H. Takagi, Y. Morishima, T. Matsuyama, H. Hayashi, T. Watanabe, H. Wada, Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker, Brain Res. 364 (1986) 114-123.
23. L. Tuomisto, U. Tacke, Is histamine an anticonvulsive inhibitory transmitter?, Neuropharmacology 25 (1986) 955-958.
24. L. Tuomisto, U. Tacke, A. Willman, Inhibition of sound-induced convulsions by metropine in the audiogenic seizure susceptible rat, Agents Actions 20 (1987) 252-254.
25. H. Wada, N. Inagaki, A. Yamatodani, T. Watanabe, Is the histaminergic neuron system a regulatory center for whole-brain activity?, Trends Neurosci. 14 (1991) 415-419.
26. T. Watanabe, Y. Taguchi, S. Shiosaka, J. Tanaka, H. Kubota, Y. Terano, M. Tohyama, H. Wada, Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker, Brain Res. 295 (1984) 13-25.
27. T. Watanabe, H. Wada (Eds.), Histaminergic Neurons: Morphology and Function, CRC Press, Boca Raton, 1991, pp. 1-412.
28. J.B. Wyngaarden, M.H. Seevers, The toxic effect of antihistaminic drugs, J. Am. Med. Assoc. 145 (1951) 277-283.
29. N. Yamada, K. Akiyama, S. Otsuki, Hippocampal kindling enhances excitatory amino acid receptor-mediated polyphosphoinositide hydrolysis in the hippocampus and amygdala/pyriform cortex, Brain Res. 490 (1989) 126-132.
30. A. Yamatodani, H. Fukuda, H. Wada, T. Iwaeda, T. Watanabe, High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with postcolumn derivatization fluorometry, J. Chromatogr. 344 (1985) 115-123.
31. H. Yokoyama, K. Onodera, K. Maeyama, K. Yanai, K. Iinuma, L. Tuomisto, T. Watanabe, Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of α-fluoromethyl-histidine and metoprine, Naunyn-Schmiedeberg's Arch. Pharmacol. 346 (1992) 40-45.
32. 3 receptor antagonist, on electrically induced convulsions in mice, Eur. J. Pharmacol. 234 (1993) 129-133.
33. 1-antagonists on electrically-induced seizure in developing mice, Psychopharmacology 112 (1993) 199-203.
34. 11C-doxepin, in: K. Uemura, et al. (Eds.), Quantification of Brain Function. Tracer Kinetics and Image Analysis in Brain PET, Elsevier, Amsterdam, 1993, pp. 297-301.
35. 1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography, Methods Find. Exp. Clin. Pharmacol. 15 (1993) 183-188.
36. 3 receptor antagonist, inhibits electrically-induced convulsions in mice, Eur. J. Pharmacol. 260 (1994) 23-28.
37. 1 agonist, decreases seizure susceptibility in mice, Pharmacol. Biochem. Behav. 47 (1994) 503-507.
38. 1 antagonists promote the development of amygdala kindling in rats, Neurosci. Lett. 217 (1996) 194-196.